AFT Pharmaceuticals to licence Maxigesic in 69 more countries

The Auckland-based drugmaker, AFT Pharmaceuticals, is partnering with a Swiss-based pharmaceutical company to licence its painkiller, Maxigesic, for sale in a further 69 countries.